You Are Here: U.S. Preventive Services Task Force > Topic Index > Hormone Replacement Therapy
Hormone Replacement Therapy for the Prevention of Chronic Conditions in Postmenopausal Women
Release Date: May 2005
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on hormone replacement therapy.
Summary of Recommendations / Supporting Documents
Summary of Recommendations
- The U.S. Preventive Services Task Force (USPSTF) recommends against the routine use of combined estrogen and progestin for the prevention of chronic conditions in postmenopausal women.
Grade: D Recommendation. - The USPSTF recommends against the routine use of unopposed estrogen for the prevention of chronic conditions in postmenopausal women who have had a hysterectomy.
Grade: D Recommendation.
Supporting Documents
Hormone Replacement Therapy, May 2005
Recommendation Statement (PDF File, 102 KB; PDF Help)
Summary of the Evidence, 2002 (PDF File, 138 KB; PDF Help)
Systematic Evidence Reviews, August 2002:
HRT and Breast Cancer (PDF Files Download)
HRT and Cardiovascular Disease (PDF Files Download)
HRT and Cognition (PDF Files Download)
HRT and Osteoporosis (PDF Files Download)
HRT and Venous Thromboembolism (PDF Files Download)
Current as of May 2005
Internet Citation:
Hormone Replacement Therapy for the Prevention of Chronic Conditions in Postmenopausal Women, Topic Page. May 2005. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspspmho.htm
USPSTF Program Office |
